Zuri Health, a telemedicine company that provides affordable healthcare services to patients across Africa via mobile app, website, WhatsApp chatbot, and SMS service, secured an undisclosed amount of investment from UM6P Ventures, an African early-stage venture capital firm.
According to the press release, the new funds will help Zuri Health expand its market and business reach across Africa. The funds will be used to hire more employees to improve the company’s telemedicine platform.
Commenting on the funding news announcement, Zuri Health’s Chief Operating Officer and Co-Founder, Titilola Olaolu-Hassan, said: “Being at the helm of a rapidly growing and evolving company like Zuri Health is an interesting challenge. The company’s growth rate shows that we are doing something right. We will continue to improve our operations and services to serve people better.”
According to Zuri Health, its telemedicine app allows patients to chat and consult with doctors, buy medication from pharmacies, book labs, and diagnostic tests, schedule home visits with licensed medical doctors.
Since launching in 2021, Zuri Health has onboarded over 600+ doctors to its platform and acquired over 16 pharmacy partners and 29 lab partners, including PharmaPlus and Ilara Health. Through these partnerships, Zuri Health has recorded over 10,000 lab and pharmacy orders and 24,000 WhatsApp Bot interactions.
Investors
“UM6P Ventures is excited to be a part of this innovative healthcare solution and looks forward to supporting the growth of the startup in the future. With this investment, the startup will be able to make a positive impact on the healthcare industry and improve the lives of patients all over the world,” the venture capital firm said in a press statement.
Telehealth and telemedicine funding
According to our database, over 300 telehealth and telemedicine companies have raised nearly $25 billion in venture capital funding to date. More recently, Doctor Anywhere, a Singapore-based telehealth company, raised $38.8 million in a Series C funding round. Novo Holdings led the investment round with participation from existing shareholders, including Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, EDBI, and OSK-SBI Venture Partners. In another deal, Nectar, a virtual allergy care provider, announced its $16.5 million Series A round led by Harmony Partners.
